Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review
- PMID: 19640737
- DOI: 10.1016/j.jvir.2009.05.030
Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review
Abstract
The past decade has seen significant advancement in the locoregional management of liver tumors; novel and promising therapies such as transarterial chemoembolization, radioembolization, and radiofrequency ablation are now available. The development of new techniques and devices has led to the improved safety and efficacy profiles of external-beam radiation. Radioembolization with yttrium-90 ((90)Y) microspheres has emerged as a safe and efficacious treatment modality for liver malignancies. The purpose of this article is to present a comprehensive evidence-based review of the complications and adverse events that may be associated with radioembolization with (90)Y microspheres. Strategies to mitigate these adverse events are also discussed.
Similar articles
-
Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.Q J Nucl Med Mol Imaging. 2009 Jun;53(3):311-6. Q J Nucl Med Mol Imaging. 2009. PMID: 19521310 Review.
-
Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.Future Oncol. 2007 Feb;3(1):73-81. doi: 10.2217/14796694.3.1.73. Future Oncol. 2007. PMID: 17280504 Review.
-
Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery.J Vasc Interv Radiol. 2009 Jun;20(6):833-6. doi: 10.1016/j.jvir.2009.03.011. Epub 2009 May 5. J Vasc Interv Radiol. 2009. PMID: 19406668
-
Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.J Vasc Interv Radiol. 2006 Oct;17(10):1571-93. doi: 10.1097/01.RVI.0000236744.34720.73. J Vasc Interv Radiol. 2006. PMID: 17056999 Review.
-
Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1494-500. doi: 10.1016/j.ijrobp.2008.10.005. Epub 2009 Jan 20. Int J Radiat Oncol Biol Phys. 2009. PMID: 19157721
Cited by
-
Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting.EJNMMI Res. 2013 Jul 25;3(1):56. doi: 10.1186/2191-219X-3-56. EJNMMI Res. 2013. PMID: 23883566 Free PMC article.
-
Local Treatment of Breast Cancer Liver Metastasis.Cancers (Basel). 2019 Sep 11;11(9):1341. doi: 10.3390/cancers11091341. Cancers (Basel). 2019. PMID: 31514362 Free PMC article. Review.
-
Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions.World J Gastroenterol. 2019 Aug 28;25(32):4614-4628. doi: 10.3748/wjg.v25.i32.4614. World J Gastroenterol. 2019. PMID: 31528090 Free PMC article. Review.
-
Intraarterial Therapies for the Management of Hepatocellular Carcinoma.Cancers (Basel). 2022 Jul 10;14(14):3351. doi: 10.3390/cancers14143351. Cancers (Basel). 2022. PMID: 35884412 Free PMC article. Review.
-
Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours.Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):231-7. doi: 10.1007/s00259-013-2550-4. Epub 2013 Sep 13. Eur J Nucl Med Mol Imaging. 2014. PMID: 24030669 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous